Influenza vaccination as secondary prevention for cardiovascular disease : A science advisory from the american heart association/ american college of cardiology
Evidence from cohort studies and a randomized clinical trial indicates that annual vaccination against seasonal influenza prevents cardiovascular morbidity and all-cause mortality in patients with cardiovascular conditions. The American Heart Association and American College of Cardiology recommend...
Gespeichert in:
| Veröffentlicht in: | Journal of the American College of Cardiology 2006-10, Vol.48 (7), p.1498-1502 |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1502 |
|---|---|
| container_issue | 7 |
| container_start_page | 1498 |
| container_title | Journal of the American College of Cardiology |
| container_volume | 48 |
| creator | DAVIS, Matthew M TAUBERT, Kathryn BENIN, Andrea L BROWN, David W MENSAH, George A BADDOUR, Larry M DUNBAR, Sandra KRUMHOLZ, Harlan M |
| description | Evidence from cohort studies and a randomized clinical trial indicates that annual vaccination against seasonal influenza prevents cardiovascular morbidity and all-cause mortality in patients with cardiovascular conditions. The American Heart Association and American College of Cardiology recommend influenza immunization with inactivated vaccine (administered intramuscularly) as part of comprehensive secondary prevention in persons with coronary and other atherosclerotic vascular disease (Class I, Level B). Immunization with live, attenuated vaccine (administered intranasally) is not currently recommended [corrected] for persons with cardiovascular conditions. It is important to note that influenza vaccination coverage levels overall and in this population remain well below national goals and are marked by disparities across different age and ethnic groups. One of the barriers to vaccination for patients with cardiovascular disease is that cardiology practices frequently do not stock and administer influenza vaccine. Healthcare providers who treat individuals with cardiovascular disease can help improve influenza vaccination coverage rates by providing and strongly recommending vaccination to their patients before and throughout the influenza season. |
| doi_str_mv | 10.1016/j.jacc.2006.09.004 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_68912376</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>68912376</sourcerecordid><originalsourceid>FETCH-LOGICAL-h302t-f14954207d4be08aac6c1d90b2408092a679cef33600a5c8f5bda27067989c423</originalsourceid><addsrcrecordid>eNpdkE9v1DAQxS0EotvCF-CALCF6Szp24tjmVlX8qVSJC5yjWWfS9SqxFztZqXwbvimmLKrEaaQ3v3lv9Bh7I6AWILqrfb1H52oJ0NVga4D2GdsIpUzVKKufsw3oRlUCrD5j5znvoYBG2JfsTGgQYCRs2K_bME4rhZ_Ij8XMB1x8DBwzz-RiGDA98EOiI4VHfYyJO0yDj0fMbp0w8cFnwkz8A7_m2XkKjjgOR59jOR1TnPmyK8pMyTsMfEeYluKfo_OPWVdPOxenie6Jx_EUMsX7h1fsxYhTptenecG-f_r47eZLdff18-3N9V21a0Au1Shaq1oJemi3BAbRdU4MFrayBQNWYqeto7FpOgBUzoxqO6DUUGRjXSubC3b51_eQ4o-V8tLPPjuaJgwU19x3xgrZ6K6A7_4D93FNofzWCwWd0FrJP9TbE7VuZxr6Q_JzKbP_V30B3p-A0iROY8LgfH7ijOiMAtP8Bm0mliA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1506177526</pqid></control><display><type>article</type><title>Influenza vaccination as secondary prevention for cardiovascular disease : A science advisory from the american heart association/ american college of cardiology</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>DAVIS, Matthew M ; TAUBERT, Kathryn ; BENIN, Andrea L ; BROWN, David W ; MENSAH, George A ; BADDOUR, Larry M ; DUNBAR, Sandra ; KRUMHOLZ, Harlan M</creator><creatorcontrib>DAVIS, Matthew M ; TAUBERT, Kathryn ; BENIN, Andrea L ; BROWN, David W ; MENSAH, George A ; BADDOUR, Larry M ; DUNBAR, Sandra ; KRUMHOLZ, Harlan M ; American Association of Cardiovascular and Pulmonary Rehabilitation ; American Diabetes Association ; American Association of Heart Failure Nurses ; American Academy of Nurse Practitioners ; American Heart Association ; Heart Failure Society of America ; Centers for Disease Control and Prevention and the Advisory Committee on Immunization ; American College of Cardiology ; Association of Black Cardiologists, Inc ; American Association of Critical Care Nurses ; Preventive Cardiovascular Nurses Association</creatorcontrib><description>Evidence from cohort studies and a randomized clinical trial indicates that annual vaccination against seasonal influenza prevents cardiovascular morbidity and all-cause mortality in patients with cardiovascular conditions. The American Heart Association and American College of Cardiology recommend influenza immunization with inactivated vaccine (administered intramuscularly) as part of comprehensive secondary prevention in persons with coronary and other atherosclerotic vascular disease (Class I, Level B). Immunization with live, attenuated vaccine (administered intranasally) is not currently recommended [corrected] for persons with cardiovascular conditions. It is important to note that influenza vaccination coverage levels overall and in this population remain well below national goals and are marked by disparities across different age and ethnic groups. One of the barriers to vaccination for patients with cardiovascular disease is that cardiology practices frequently do not stock and administer influenza vaccine. Healthcare providers who treat individuals with cardiovascular disease can help improve influenza vaccination coverage rates by providing and strongly recommending vaccination to their patients before and throughout the influenza season.</description><identifier>ISSN: 0735-1097</identifier><identifier>EISSN: 1558-3597</identifier><identifier>DOI: 10.1016/j.jacc.2006.09.004</identifier><identifier>PMID: 17010820</identifier><identifier>CODEN: JACCDI</identifier><language>eng</language><publisher>New York, NY: Elsevier Science</publisher><subject>Adult ; Age ; Age Factors ; Aged ; Biological and medical sciences ; Cardiology ; Cardiology. Vascular system ; Cardiovascular disease ; Cardiovascular Diseases - complications ; Chronic illnesses ; Colleges & universities ; Contraindications ; Diabetes ; Ethnic Groups ; Human viral diseases ; Humans ; Hypotheses ; Immunization Schedule ; Infections ; Infectious diseases ; Influenza ; Influenza Vaccines - supply & distribution ; Influenza Vaccines - therapeutic use ; Influenza, Human - mortality ; Influenza, Human - prevention & control ; Medical sciences ; Middle Aged ; Mortality ; Risk Factors ; Seasons ; Vaccination - utilization ; Vaccines ; Vaccines, Attenuated - therapeutic use ; Vaccines, Inactivated - therapeutic use ; Viral diseases ; Viral diseases of the respiratory system and ent viral diseases ; Viral infections ; Viruses ; Writing</subject><ispartof>Journal of the American College of Cardiology, 2006-10, Vol.48 (7), p.1498-1502</ispartof><rights>2006 INIST-CNRS</rights><rights>Copyright Elsevier Limited Oct 3, 2006</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18168508$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17010820$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>DAVIS, Matthew M</creatorcontrib><creatorcontrib>TAUBERT, Kathryn</creatorcontrib><creatorcontrib>BENIN, Andrea L</creatorcontrib><creatorcontrib>BROWN, David W</creatorcontrib><creatorcontrib>MENSAH, George A</creatorcontrib><creatorcontrib>BADDOUR, Larry M</creatorcontrib><creatorcontrib>DUNBAR, Sandra</creatorcontrib><creatorcontrib>KRUMHOLZ, Harlan M</creatorcontrib><creatorcontrib>American Association of Cardiovascular and Pulmonary Rehabilitation</creatorcontrib><creatorcontrib>American Diabetes Association</creatorcontrib><creatorcontrib>American Association of Heart Failure Nurses</creatorcontrib><creatorcontrib>American Academy of Nurse Practitioners</creatorcontrib><creatorcontrib>American Heart Association</creatorcontrib><creatorcontrib>Heart Failure Society of America</creatorcontrib><creatorcontrib>Centers for Disease Control and Prevention and the Advisory Committee on Immunization</creatorcontrib><creatorcontrib>American College of Cardiology</creatorcontrib><creatorcontrib>Association of Black Cardiologists, Inc</creatorcontrib><creatorcontrib>American Association of Critical Care Nurses</creatorcontrib><creatorcontrib>Preventive Cardiovascular Nurses Association</creatorcontrib><title>Influenza vaccination as secondary prevention for cardiovascular disease : A science advisory from the american heart association/ american college of cardiology</title><title>Journal of the American College of Cardiology</title><addtitle>J Am Coll Cardiol</addtitle><description>Evidence from cohort studies and a randomized clinical trial indicates that annual vaccination against seasonal influenza prevents cardiovascular morbidity and all-cause mortality in patients with cardiovascular conditions. The American Heart Association and American College of Cardiology recommend influenza immunization with inactivated vaccine (administered intramuscularly) as part of comprehensive secondary prevention in persons with coronary and other atherosclerotic vascular disease (Class I, Level B). Immunization with live, attenuated vaccine (administered intranasally) is not currently recommended [corrected] for persons with cardiovascular conditions. It is important to note that influenza vaccination coverage levels overall and in this population remain well below national goals and are marked by disparities across different age and ethnic groups. One of the barriers to vaccination for patients with cardiovascular disease is that cardiology practices frequently do not stock and administer influenza vaccine. Healthcare providers who treat individuals with cardiovascular disease can help improve influenza vaccination coverage rates by providing and strongly recommending vaccination to their patients before and throughout the influenza season.</description><subject>Adult</subject><subject>Age</subject><subject>Age Factors</subject><subject>Aged</subject><subject>Biological and medical sciences</subject><subject>Cardiology</subject><subject>Cardiology. Vascular system</subject><subject>Cardiovascular disease</subject><subject>Cardiovascular Diseases - complications</subject><subject>Chronic illnesses</subject><subject>Colleges & universities</subject><subject>Contraindications</subject><subject>Diabetes</subject><subject>Ethnic Groups</subject><subject>Human viral diseases</subject><subject>Humans</subject><subject>Hypotheses</subject><subject>Immunization Schedule</subject><subject>Infections</subject><subject>Infectious diseases</subject><subject>Influenza</subject><subject>Influenza Vaccines - supply & distribution</subject><subject>Influenza Vaccines - therapeutic use</subject><subject>Influenza, Human - mortality</subject><subject>Influenza, Human - prevention & control</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Mortality</subject><subject>Risk Factors</subject><subject>Seasons</subject><subject>Vaccination - utilization</subject><subject>Vaccines</subject><subject>Vaccines, Attenuated - therapeutic use</subject><subject>Vaccines, Inactivated - therapeutic use</subject><subject>Viral diseases</subject><subject>Viral diseases of the respiratory system and ent viral diseases</subject><subject>Viral infections</subject><subject>Viruses</subject><subject>Writing</subject><issn>0735-1097</issn><issn>1558-3597</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkE9v1DAQxS0EotvCF-CALCF6Szp24tjmVlX8qVSJC5yjWWfS9SqxFztZqXwbvimmLKrEaaQ3v3lv9Bh7I6AWILqrfb1H52oJ0NVga4D2GdsIpUzVKKufsw3oRlUCrD5j5znvoYBG2JfsTGgQYCRs2K_bME4rhZ_Ij8XMB1x8DBwzz-RiGDA98EOiI4VHfYyJO0yDj0fMbp0w8cFnwkz8A7_m2XkKjjgOR59jOR1TnPmyK8pMyTsMfEeYluKfo_OPWVdPOxenie6Jx_EUMsX7h1fsxYhTptenecG-f_r47eZLdff18-3N9V21a0Au1Shaq1oJemi3BAbRdU4MFrayBQNWYqeto7FpOgBUzoxqO6DUUGRjXSubC3b51_eQ4o-V8tLPPjuaJgwU19x3xgrZ6K6A7_4D93FNofzWCwWd0FrJP9TbE7VuZxr6Q_JzKbP_V30B3p-A0iROY8LgfH7ijOiMAtP8Bm0mliA</recordid><startdate>20061003</startdate><enddate>20061003</enddate><creator>DAVIS, Matthew M</creator><creator>TAUBERT, Kathryn</creator><creator>BENIN, Andrea L</creator><creator>BROWN, David W</creator><creator>MENSAH, George A</creator><creator>BADDOUR, Larry M</creator><creator>DUNBAR, Sandra</creator><creator>KRUMHOLZ, Harlan M</creator><general>Elsevier Science</general><general>Elsevier Limited</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7T5</scope><scope>7TK</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>20061003</creationdate><title>Influenza vaccination as secondary prevention for cardiovascular disease : A science advisory from the american heart association/ american college of cardiology</title><author>DAVIS, Matthew M ; TAUBERT, Kathryn ; BENIN, Andrea L ; BROWN, David W ; MENSAH, George A ; BADDOUR, Larry M ; DUNBAR, Sandra ; KRUMHOLZ, Harlan M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-h302t-f14954207d4be08aac6c1d90b2408092a679cef33600a5c8f5bda27067989c423</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Adult</topic><topic>Age</topic><topic>Age Factors</topic><topic>Aged</topic><topic>Biological and medical sciences</topic><topic>Cardiology</topic><topic>Cardiology. Vascular system</topic><topic>Cardiovascular disease</topic><topic>Cardiovascular Diseases - complications</topic><topic>Chronic illnesses</topic><topic>Colleges & universities</topic><topic>Contraindications</topic><topic>Diabetes</topic><topic>Ethnic Groups</topic><topic>Human viral diseases</topic><topic>Humans</topic><topic>Hypotheses</topic><topic>Immunization Schedule</topic><topic>Infections</topic><topic>Infectious diseases</topic><topic>Influenza</topic><topic>Influenza Vaccines - supply & distribution</topic><topic>Influenza Vaccines - therapeutic use</topic><topic>Influenza, Human - mortality</topic><topic>Influenza, Human - prevention & control</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Mortality</topic><topic>Risk Factors</topic><topic>Seasons</topic><topic>Vaccination - utilization</topic><topic>Vaccines</topic><topic>Vaccines, Attenuated - therapeutic use</topic><topic>Vaccines, Inactivated - therapeutic use</topic><topic>Viral diseases</topic><topic>Viral diseases of the respiratory system and ent viral diseases</topic><topic>Viral infections</topic><topic>Viruses</topic><topic>Writing</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>DAVIS, Matthew M</creatorcontrib><creatorcontrib>TAUBERT, Kathryn</creatorcontrib><creatorcontrib>BENIN, Andrea L</creatorcontrib><creatorcontrib>BROWN, David W</creatorcontrib><creatorcontrib>MENSAH, George A</creatorcontrib><creatorcontrib>BADDOUR, Larry M</creatorcontrib><creatorcontrib>DUNBAR, Sandra</creatorcontrib><creatorcontrib>KRUMHOLZ, Harlan M</creatorcontrib><creatorcontrib>American Association of Cardiovascular and Pulmonary Rehabilitation</creatorcontrib><creatorcontrib>American Diabetes Association</creatorcontrib><creatorcontrib>American Association of Heart Failure Nurses</creatorcontrib><creatorcontrib>American Academy of Nurse Practitioners</creatorcontrib><creatorcontrib>American Heart Association</creatorcontrib><creatorcontrib>Heart Failure Society of America</creatorcontrib><creatorcontrib>Centers for Disease Control and Prevention and the Advisory Committee on Immunization</creatorcontrib><creatorcontrib>American College of Cardiology</creatorcontrib><creatorcontrib>Association of Black Cardiologists, Inc</creatorcontrib><creatorcontrib>American Association of Critical Care Nurses</creatorcontrib><creatorcontrib>Preventive Cardiovascular Nurses Association</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of the American College of Cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>DAVIS, Matthew M</au><au>TAUBERT, Kathryn</au><au>BENIN, Andrea L</au><au>BROWN, David W</au><au>MENSAH, George A</au><au>BADDOUR, Larry M</au><au>DUNBAR, Sandra</au><au>KRUMHOLZ, Harlan M</au><aucorp>American Association of Cardiovascular and Pulmonary Rehabilitation</aucorp><aucorp>American Diabetes Association</aucorp><aucorp>American Association of Heart Failure Nurses</aucorp><aucorp>American Academy of Nurse Practitioners</aucorp><aucorp>American Heart Association</aucorp><aucorp>Heart Failure Society of America</aucorp><aucorp>Centers for Disease Control and Prevention and the Advisory Committee on Immunization</aucorp><aucorp>American College of Cardiology</aucorp><aucorp>Association of Black Cardiologists, Inc</aucorp><aucorp>American Association of Critical Care Nurses</aucorp><aucorp>Preventive Cardiovascular Nurses Association</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Influenza vaccination as secondary prevention for cardiovascular disease : A science advisory from the american heart association/ american college of cardiology</atitle><jtitle>Journal of the American College of Cardiology</jtitle><addtitle>J Am Coll Cardiol</addtitle><date>2006-10-03</date><risdate>2006</risdate><volume>48</volume><issue>7</issue><spage>1498</spage><epage>1502</epage><pages>1498-1502</pages><issn>0735-1097</issn><eissn>1558-3597</eissn><coden>JACCDI</coden><abstract>Evidence from cohort studies and a randomized clinical trial indicates that annual vaccination against seasonal influenza prevents cardiovascular morbidity and all-cause mortality in patients with cardiovascular conditions. The American Heart Association and American College of Cardiology recommend influenza immunization with inactivated vaccine (administered intramuscularly) as part of comprehensive secondary prevention in persons with coronary and other atherosclerotic vascular disease (Class I, Level B). Immunization with live, attenuated vaccine (administered intranasally) is not currently recommended [corrected] for persons with cardiovascular conditions. It is important to note that influenza vaccination coverage levels overall and in this population remain well below national goals and are marked by disparities across different age and ethnic groups. One of the barriers to vaccination for patients with cardiovascular disease is that cardiology practices frequently do not stock and administer influenza vaccine. Healthcare providers who treat individuals with cardiovascular disease can help improve influenza vaccination coverage rates by providing and strongly recommending vaccination to their patients before and throughout the influenza season.</abstract><cop>New York, NY</cop><pub>Elsevier Science</pub><pmid>17010820</pmid><doi>10.1016/j.jacc.2006.09.004</doi><tpages>5</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0735-1097 |
| ispartof | Journal of the American College of Cardiology, 2006-10, Vol.48 (7), p.1498-1502 |
| issn | 0735-1097 1558-3597 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_68912376 |
| source | MEDLINE; Elsevier ScienceDirect Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection |
| subjects | Adult Age Age Factors Aged Biological and medical sciences Cardiology Cardiology. Vascular system Cardiovascular disease Cardiovascular Diseases - complications Chronic illnesses Colleges & universities Contraindications Diabetes Ethnic Groups Human viral diseases Humans Hypotheses Immunization Schedule Infections Infectious diseases Influenza Influenza Vaccines - supply & distribution Influenza Vaccines - therapeutic use Influenza, Human - mortality Influenza, Human - prevention & control Medical sciences Middle Aged Mortality Risk Factors Seasons Vaccination - utilization Vaccines Vaccines, Attenuated - therapeutic use Vaccines, Inactivated - therapeutic use Viral diseases Viral diseases of the respiratory system and ent viral diseases Viral infections Viruses Writing |
| title | Influenza vaccination as secondary prevention for cardiovascular disease : A science advisory from the american heart association/ american college of cardiology |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T18%3A05%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Influenza%20vaccination%20as%20secondary%20prevention%20for%20cardiovascular%20disease%20:%20A%20science%20advisory%20from%20the%20american%20heart%20association/%20american%20college%20of%20cardiology&rft.jtitle=Journal%20of%20the%20American%20College%20of%20Cardiology&rft.au=DAVIS,%20Matthew%20M&rft.aucorp=American%20Association%20of%20Cardiovascular%20and%20Pulmonary%20Rehabilitation&rft.date=2006-10-03&rft.volume=48&rft.issue=7&rft.spage=1498&rft.epage=1502&rft.pages=1498-1502&rft.issn=0735-1097&rft.eissn=1558-3597&rft.coden=JACCDI&rft_id=info:doi/10.1016/j.jacc.2006.09.004&rft_dat=%3Cproquest_pubme%3E68912376%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1506177526&rft_id=info:pmid/17010820&rfr_iscdi=true |